Lulizumab Pegol
Lulizumab Pegol Uses, Dosage, Side Effects, Food Interaction and all others data.
Lulizumab Pegol is under investigation in clinical trial NCT02843659 (Proof of Concept Study to Evaluate the Efficacy and Safety of BMS-931699 (Lulizumab) or BMS-986142 in Primary Sjögren's Syndrome).
| Trade Name | Lulizumab Pegol |
| Generic | Lulizumab pegol |
| Lulizumab pegol Other Names | BMS-931699, Lulizumab pegol |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Lulizumab Pegol
